Keyword: Cleveland Clinic
The $400 million deal gives Novo worldwide rights to an epigenetic treatment of the disease that is closing in on the start of a phase 2 trial.
Cleveland Clinic researchers depleted BACE1 to reverse amyloid plaque formation in mice with Alzheimer's disease.
A stem cell pathway could be targeted to create more effective treatments for triple-negative breast cancer.
A new study has shown promise in mice for an experimental drug for Alzheimer's disease.